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Summary We studied the cell migration properties of poorly metastatic murine RAW117-P large-cell lym-
phoma cells, a highly lung metastatic subline (RAW117-L17) and a highly liver metastatic subline (RAW117-
H10). L17 cells responded to the serum-free conditioned medium (CM) of mouse lung microvessel endothelial
cells (MLEs) and mouse lung fibroblasts (MLFs). The migration of L17 cells was also stimulated by its own
CM and, to a lesser extent, by the CM of parental (P) and H1O cells. RAW117-P and -H1O cells responded
poorly to all of the CM tested. Chequerboard analyses revealed that the migration-stimulating activities of
MLE CM and MLF CM were mainly chemotactic, whereas those of L17, P and H1O CM were chemokinetic.
We also analysed the effect of MLE CM and MLF CM in combination with L17, P or H1O CM on cell
migration of the RAW117 sublines. The migration of lung metastatic subline L17 cells to MLE or MLF CM
was enhanced when L17 CM was also present. This enhancement effect was not seen when P or H1O cells were
exposed to MLE or MLF CM plus the CM from P or H1O cells respectively. Thus we found that the
chemotactic response of lung metastatic large-cell lymphoma cells to paracrine migration stimulation factors
from lung endothelial cells and fibroblasts in concert with an autocrine chemokinetic factor may be involved in
RAW117 lung-specific invasion and metastasis.
The invasion and metastasis of malignant cells probably
accounts for the majority of cancer deaths. Using sequential
in vivo selection methods, highly malignant tumour cell
clones or subpopulations with the ability to metastasise to
certain organs have been obtained (Fidler, 1973; Brunson &
Nicolson, 1978; Miner et al., 1982; Neri et al., 1982). The
success of this approach with some tumour systems has lent
support to the concept that particular tumour cell subpopula-
tions prefer to metastasise to certain organ sites (Paget,
1889). In addition, these experimental metastatic models have
enabled us to determine the tumour and host factors
involved in invasion and metastasis and have provided clues
to the development of future anti-metastatic therapies.
The poorly metastatic murine RAW117 large-cell lym-
phoma parental cell line (RAW117-P) has been used to select
sequentially highly lung metastatic (RAW117-L17) and
highly liver metastatic (RAW117-H10) sublines (Brunson &
Nicolson, 1978; Miner & Nicolson, 1983). These organ-
selected sublines show enhanced ability to colonise the
selected site in vivo and higher rates of invasion of target
organ tissues in vitro. For example, cells of the lung meta-
static subline L17 invaded lung tissue fragments at higher
rates than did P or HIO cells (Nicolson et al., 1989), implying
that certain tumour cell properties and perhaps host factors
might be responsible for this invasion preference. The ability
of RAW117 cells to adhere to lung microvessel endothelial
cells or their extracellular matrix and to proliferate in re-
sponse to conditioned medium from the lung has been inves-
tigated, and these properties have been related to lung
metastatic potential (Nicolson, 1987; Nicolson et al., 1989;
Cavanaugh & Nicolson, 1990).
Tumour cell migration is thought to be an important
property of invasion and extravasation (Striiuli & Weiss,
1977; Russo et al., 1983). Two different mechanisms of
tumour cell migration have been proposed: the chemotactic
attraction of tumour cells to host cell paracrine factors
(Hujanen & Terranova, 1985; Cerra & Nathanson, 1989) and
the activation of tumour cell chemokinetic motility by re-
sponse to autocrine factors (Atnip et al., 1987; Silletti et al.,
1991; Stracke et al., 1992). We analysed the migratory re-
sponses of murine RAW117 cells of varying lung-colonising
abilities towards paracrine factors produced by normal
syngeneic lung endothelial cells (MLEs) and syngeneic lung
fibroblasts (MLFs). In addition, we examined the possibility
that RAW117 cells secrete autocrine motility factors. Our
results suggest that lung metastatic RAW117 tumour cells
respond to paracrine motility factors secreted by normal lung
cells and to autocrine factors and that the responses to these
migration factors may explain, in part, the preference of lung
metastasis seen in the L17 subline.
Materials and methods
Cells and culture conditions
RAW117 large-cell lymphoma cell lines (RAW117-P,
RAW117-L17 and RAW117-H1O) were maintained as sus-
pension cultures in plastic Petri dishes (Falcon, Lincoln Park,
NJ, USA) in Dulbecco's modified Eagle medium (DME)
supplemented with high-glucose (4.5 g 1V), 25 mM HEPES
buffer (DME-HG) and 5% fetal bovine serum (FBS) (Nicol-
son et al., 1982). Mouse lung microvessel endothelial cells,
isolated by collagenase digestion from the microvasculatures
of mouse lung, and confirmed by cobblestone appearance,
non-thrombogenic surface, presence of factor VIII and bind-
ing of acetylated low-density lipoprotein as previously de-
scribed (Belloni et al., 1992), were cultured on gelatin-coated
tissue culture dishes (Corning Laboratory Sciences, Park
Ridge, IL, USA) in a 1: 1 (v/v) mixture of DME and Ham's
F12 medium (DME/F12) supplemented with 5% FBS and
50pg ml1 ' endothelial cell mitogen (Biomedical Techno-
logies, Stroughton, MA, USA). Primary mouse lung fibro-
blasts (Belloni et al., 1992) were cultured on tissue culture
dishes in DME/F12 containing 5% FBS. A highly lung
metastatic variant (MTLn3) of the rat 13762NF mammary
adenocarcinoma was maintained as culture on tissue culture
dishes in alpha-modified minimal essential medium (x-MEM,
Gibco, Grand Island, NY, USA) supplemented with 5% FBS
(Neri et al., 1982).
Conditioned medium (CM)
When MLEs, MLFs and MTLn3 cells reached confluence or
a suspension culture density of approximately 2 x 106ml-'
(RAW117 cell lines), the cells were washed twice in the
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medium appropriate for each cell line and suspended in the
same medium for 1 day. Each cell line was washed again,
and fresh serum-free medium was added at a volume of
10ml per 100mm dish. MLF, MLF, MTLn3 or RAW117
cell-conditioned medium was collected after 8 days, 4 days, 1
day, respectively, and centrifuged at 800g for Omin, and
the supernatants were recentrifuged at 25,000g for 1 h. The
supernatants were passed through filters (0.22 lim). Phenyl
methyl sulphonyl fluoride at 1 mM (Sigma, St Louis, MO,
USA), 100 jiM iodoacetamide (Sigma), 1 jiM E-64 (Boehringer
Mannheim, Indianapolis, IN, USA) and 1 mM EDTA (Sigma)
at the indicated final concentrations were added, and the CM
were concentrated on a Diaflo ultrafiltration membrane with
a molecular weight cut-off of 10,000 (Amicon, Beverly, MA,
USA), and dialysed against 1OmM HEPES, 0.13 M sodium
chloride, pH 7.3. The protease inhibitor treatment itself did
not change the activities of the CM. The protein amounts of
the concentrated CM were determined by Coomassie blue
plus protein assay reagent (Pierce, Rockford, IL, USA).
Cell migration assay
RAW 17 cells used in this assay were from early passages
that had not undergone phenotypic drift (Nicolson et al.,
1982). Migration-stimulating activities of RAWI 17 CM were
assayed according to Repesh (1989) with some modifications.
Concentrated CM were made 1 x in medium components
and 500jigml-' bovine serum albumin (BSA) by the addi-
tion of 10 x DME-HG and 5 mg ml1l BSA. CM (600jil) was
placed in the lower chamber of a Transwell (Costar, Cam-
bridge, MA, USA) containing a 3 jim pore sized filter.
RAW117 cells were washed twice with DME-HG, and 100 jil
of a cell suspension (1.8 x 106 ml1 in DME-HG containing
500jig ml-' BSA and 0.13 M sodium chloride) was added to
the upper chamber. After a 2 h incubation at 37'C, the cells
that migrated through the filter and were loosely attached to
the lower surface of the filter were detached by soft but
extensive tapping of the Transwell. The cells released into the
lower chamber were counted with a Coulter counter (Model
ZM, Coulter Electronics, Hialeah, FL, USA). Standard
deviations were calculated for the data in each experiment.
P-values were calculated according to Student's t-test.
Results
Migration ofRAWJ17 cells stimulated by MLE CM and
MLF CM
RAWI 17-L17 cell migration was stimulated in a dose-
dependent manner by both MLE and MLF CM (MLE
CM> MLF CM, P<0.002) (Figure 1, Table I). To facilitate
comparison of migration-stimulation activities among the
RAW117 cell lines, the amounts of CM are shown as protein
concentration. The migration-stimulating factors in CM were
Table I Migration response of RAWI 17 cells towards conditioned
medium from RAW117 cells, lung endothelial cells, lung fibroblasts
or mammary adenocarcinoma cells
.0
E
C
0
l**
Protein concentration (jig ml-')
Figure 1 Migration of RAWI 17 cell lines stimulated by MLE
CM or MLF CM. Cell numbers migrating across the filter were
determined after a 2 h incubation as described in the Materials
and methods section. Each point and bar indicates migrated cell
number ± s.d. of RAW117-L17 (squares), RAW117-P (circles) or
RAW117-H1O (triangles) cells at the indicated protein concentra-
tion of MLE CM (open symbols) or MLF CM (closed symbols).
The values represent duplicate experiments (*P<0.01, L17 > P,
HIO; **P<0.05, L17 >P; P<0.01, L17 >HIO).
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Protein concentration in upper chamber (jg ml-')
0 20 40
0 _ 3,028 (720)-- 2,452 (240) 1,600 (200)
20 8,400 (1,760)N- 4,280 (240>-_3,680 (360)
40 15,380 (1,300) 5,880 (520)Y 3,486 (234)
b
Protein concentration of upper chamber (jg ml-1)
0 20 40
0 -.t210 (1130) _ 4,274 (566) 4,980 (540)
20 10,100 (100)~-. 6,720 (120> .. 4,580 (260)
40 11,860 (300) 9,460 (20) ~ 6,200 (0) -
Figure 2 Chequerboard analysis of the migration of RAWI 17-
L17 cells stimulated by MLE CM a, or MLF CM b. The CM
was applied at the indicated protein concentration in the upper or
lower chamber of a Transwell apparatus. Cell numbers migrating
across the filter were determined after a 2 h incubation as de-
scribed in the Materials and methods section. Each value
indicates the migrated cell number (± s.d.) for duplicate
experiments.
Migration rate of RAWJJ7 cells
(correlation coefficient of ratea)
Ll7 P H1O
MLE 672 (0.920)b 88 (0.999) 25 (0.386)
MLF 556 (0.914)c 29 (0.916) 0
L17 631 (0.972)d 0 98 (0.947)
P 455 (0.98I)d 124 (0.857) 44 (0.905)
HIO 204 (0.958)' 0 44 (0.236)
MTLn3 145 (0.979)b 9 (0.747) 0
'The data from Figures 1, 3 and 5 were calculated as rate of
migrated cells (correlation coefficient) per jug of CM protein per 2 h
using the approximately linear migration responses seen between 0
and lOigmlh' CM. bP<O.Ol, L17>P, HIO. cP<0.055 L17>P;
P<0.01, L17>H10. dp<0.OOl, L17>P, H1O. ep<0.001,
L17>P.
found to be trypsin sensitive (data not shown). Also, the cell
sizes of the three RAWl 17 cell lines were essentially identical,
and thus the assay conditions could be standardised as the
rate of migrated cells per jig of protein of each attractant per
2 h. RAW117-P cell migration was only slightly stimulated
by MLE CM but not by MLF CM in a dose-dpendent
manner, and the responses were much lower than with
RAWl 17-L17 cells (Figure 1). RAWl 17-H10 cells as well as
RAWI 17-LI7 cells showed a higher basal level of migration
than was found with RAW117-P cells (L17, HlO>P;
P<0.01), and the migration of H1O cells was not increased
by addition of either MLE or MLF CM (Figure 1). Using
chequerboard analysis, the L17 migation cell number in-
creased with the increase in concentration of CM in the
lower but not the upper chamber, and therefore the
Conditioned medium
in lower chamber
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RAW117-L17 migration-stimulating activities of MLE and
MLF CM were characterised as chemotactic (Figure 2a and
b). When a concentration gradient was not formed between
the upper and lower chambers, migrated cell number did not
increase remarkably with increasing concentration of MLE
or MLF CM. Thus there was little evidence for the existence
of a chemokinetic factor in MLE or MLF CM (Figure 2a
and b respectively).
Autocrine-stimulated migration ofRAW117 cells
RAW117-L17 cells responded to all the RAW117 CM (L17
CM>P CM, P<O.OOl; P CM>HIO CM, P<O.O1) (Figure
3 and Table I). RAW117-P cells responded to only P CM.
No significant stimulation of H10 migration was seen with
any of the RAW117 CM. Using L17 as target cells, responses
to RAW117 CM were characterised by chequerboard
analysis. Migration-stimulating activities of the RAW117
CMs were chemokinetic, as shown by the increase in migra-
tion cell number with CM concentration in the absence of a
gradient of the motility factor (Figure 4). Chemotactic
activities in the RAW117 CMs were not detected.
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Figure 4 Chequerboard analysis of the migration of RAW117-
L17 cells stimulated by RAWI 17-L17 CM a, RAWI 17-P CM b,
or RAW117-H10 CM c. The CM was applied at the indicated
protein concentrations in the upper or lower chamber of a Trans-
well apparatus. Cell numbers migrating across the filter were
determined after a 2 h incubation as described in the Materials
and methods section. Each value indicates the migrated cell
number (± s.d.) in duplicate experiments.
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Figure 3 Migration of RAWI 17 cell lines stimulated by
RAWI17-L17 CM a, RAWI17-P CM b, or RAWI17-HI0 CM c.
Migrated cell numbers were determined after a 2 h incubation as
described in the Materials and methods section. Each point and
bar indicates a migrated cell number (± s.d.) of RAW117-L17
(0), RAWI17-P (0) or RAWI17-HI0(A) cells at the indicated
protein concentration of each CM in duplicate experiments
(*P<0.001, L17 >P, HIO; **P<0.001, L17 >P).
Figure 5 Migration of RAWI 17 cell lines stimulated by MTLn3
tumour cell CM. Migrated cell numbers were determined after
the incubation as described in the Materials and methods section.
Each point and bar indicates migrated cell number and (± s.d.)
of RAW117-L17 (0), RAW117-P (0) or RAWI17-H10(A) at
the various CM protein concentrations in duplicate experiments
(*P<0.01, L17 >P, HIO).
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Migration response ofRAW117 cells to MTLn3 CM
Of the RAW117 cell lines tested, only L17 migration was
significantly stimulated by MTLn3 CM (Figure 5 and Table
I), and this activity was exclusively chemotactic (Figure
6).
Migration response ofRAW117 cells to MLE CM or MLF
CMplus RAWJ17 CM
The migration responses of RAW117 cells to MLE CM or
MLF CM attained maximum levels in the assay, and the
migrated cell numbers could be calculated using double-
reciprocal plots. The correlation coefficients of the plots by
each set of the three curves in Figure 7 were 0.999 ± 0.001
(MLE-L17), 0.855 ± 0.109 (MLF-L17), 0.852 ± 0.186 (MLE-
P), 0.853 ± 0.107 (MLF-P), 0.820 ± 0.132 (MLE-H10) and
0.978 ± 0.107 (MLF-H1O). The ability of RAW117-L17 CM
to increase the migration response to MLE CM or MLF CM
was regarded as synergistic rather than as additive, because
the migrated cell number achieved with 5fig of MLE CM or
MLF CM and 20lag of L17 CM was far greater than that
seen with 25 lig of MLE CM, MLF CM or L17 CM (com-
pare Figure 7a with Figures 1 and 3). The relative ability of
various RAW117 CMs to enhance the migration of the
RAW117 cells to MLE CM or MLF CM was L17 CM>>P
CM, H1O CM (Figure 8 and Table II).
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Discussion
We have demonstrated that a highly lung-metastatic murine
RAW117 large-cell lymphoma subline (RAW117-L17) has a
significant chemotactic response to the CM of mouse MLE
lung microvessel endothelial cells and mouse lung fibroblasts.
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Table II The effect of RAW117 CM on rate ofmaximum migration
of RAWI 17 cells towards conditioned medium from lung endothelial
cells or lung fibroblasts
Conditioned medium
in lower chamber
MLE 103
MLF 113
Rate of migration of RAW117 cells
(correlation coefficient of ratea)
Ll7b pc Hiod
7 (0.995)Y 92 (0.645) 177 (0.852)
5 (0.967)f 170 (0.910) 130 (0.955)
5,0004
0
.o,uuu
aThe data from Figure 8 were calculated as rate of migrated cells
(correlation coefficient) at maximum cell number per jig of RAW1 17
CM per 2 h using the approximately linear migration responses seen
between 0 and 2OjIgml-l CM. bMLE CM or MLF CM plus L17
CM in lower chamber. CMLE CM or MLF CM plus P CM in lower
chamber. dMLE CM or MLF CM plus H10 CM in lower chamber.
ep <0.05 L17>P; P<0.01, L17>H1O. fP<0.05, L17>P;
P<0.001, L17>HIO.
30,000
25,000
D0 20,000
E
C
": 15,000
0
Protein concentration of upper chamber (jg ml-')
0 50 100
.0 E 0 o _3,974(386)'-,12,720 (1,920) 12,740 (1,100)
0 50 8,580 (380)
~ _11,820(3405" J1,880(200)
.C 0 100 9,680 (400) 11,640 (760)"-413,600 (1,080)"
o -0
X, o
10,00(
5,00(
a
D
F b
10 20
C
0 10 20
Protein concentration (,ug ml-')
Figure 6 Chequerboard analysis of the migration of RAWI 17-
L17 cells stimulated by MTLn3 tumour cell CM. The CM was
applied at the indicated protein concentration in the upper or
lower chamber of a Transwell apparatus. Each value indicates the
migrated cell number (± s.d.) in duplicate experiments as des-
cribed in the Materials and methods section.
Figure 7 Migration of RAW117 cell lines stimulated by mixtures
of CM. Migrated cell numbers were determined as described in
the Materials and methods section. Each point and bar indicates
migrated cell number (± s.d.) of RAW117-L17 a, RAW117-P b,
or RAWI 17-HI0 c, at indicated protein concentration of the
MLE CM (open symbols, solid lines) or MLF CM (closed sym-
bols, dotted lines) mixed with 0 jig (squares), 5jg (circles), or
20jig (triangles) of RAWI 17-L17 CM a, RAWI 17-P CM b, or
RAW117-H10 CM c, in duplicate experiments.
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Figure 8 Plot of maximum migration cell numbers of RAW117
cell lines to MLE CM or MLF CM. The maximum migration cell
numbers was calculated as described in the Results section. Each
point indicates the maximum cell number of RAW1 17-L17
(squares), RAW1 17-P (circles) or RAW1 17-H10 (triangles) to
MLE CM (open symbols, solid lines) or MLF CM (closed sym-
bols, dotted lines) at indicated protein concentration of mixed
RAW117 CMs (*P<0.05, L17 >P; P<0.01, L17 >H10;
**P<0.05, L17 >P; P<0.001, L17 >H10).
The migration of L17 cells was also stimulated by its own
CM and MTLn3 mammary tumour cell CM as well as by
CM from RAW117-P or -H10 cells. These responses were
correlated with the organ preference of metastasis seen in this
system for lung metastasis (L17 >>P, H10). The migratory
response of RAW117-L17 to MLE CM or MLF CM was
also synergistically enhanced by the presence of L17 CM.
This was not seen with the other RAW117 cell lines. Our
results suggest that migratory responses to paracrine factors
as well as to autocrine factors are important for lung-specific
metastasis of RAW117 cells.
The RAW117 cell line was originally derived from pre-B
lymphocytes, which are considered to be highly motile after
stimulation (Parrott & Wilkinson, 1981). Indeed, the maxi-
mum migrated cell number of RAW117-L17 cells in some
assays reached nearly 35,000 cells during a 2 h assay, corre-
sponding to almost 20% of the applied cells. These data
indicate that RAW117 cells are highly motile and that this
property might be responsible for their ability to invade lung
fragments in vitro (Nicolson et al., 1989). We found that
there were three types of migration properties differently
expressed in RAW1 17 cells: (1) inherent motility, (2)
chemotactic response to paracrine factors and (3) autocrine
motility responses to their own factors.
With regard to inherent motility of RAW117 cells, the
more highly metastatic cells of this series (L17 and HIO)
possessed higher inherent motility than the poorly metastatic
P cells when tested for inherent migratory activity in the
absence of attractant. This difference could have been due to
the difference in the secretion of and response to autocrine
motility factors. We feel, however, that this was not the case,
because the motility of H1O cells was as low as that of P cells
when the cells were tested with their own CM. It is possible
that high inherent motility might be a requirement for
general metastatic capability rather than lung metastasising
ability.
The chemotactic response of the RAW117 cells to para-
crine motility factors present in MLE CM and MLF CM
correlated with lung metastatic properties. Similarly, liver
metastatic capability has been reported to be correlated with
the chemotactic response of liver metastatic H10 cells to liver
endothelial cell CM (Hamada et al., 1992, 1993). Microvessel
endothelial cells from different organs are known to possess
different properties (Belloni & Nicolson, 1988; Belloni et al.,
1992; Hamada et al., 1992); thus, the chemoattractants pre-
sent in MLE CM and MLF CM must be different from those
of liver endothelial cell CM. The fact that MLF also secreted
chemotactic factor(s) raises the possibility that a gradient of
chemoattractant(s) from blood vessels towards the lung inter-
stitium may exist in vivo, facilitating tumour cell extra-
vasation and parenchymal invasion.
RAWI 17-L17 cells possessed much higher autocrine
motility towards their own CM. In addition, only L17 cells
responded well to MTLn3 tumour cell CM, the response to
which has been reported to relate to lung-specific metastatic
capacity (Atnip et al., 1987). Therefore, this autocrine
motility response may be related to L17's lung metastasising
preference rather than to a non-specific response.
The maximum degree of L17 cell migration differed
between the paracrine and autocrine assays used to measure
cell migration. L17 chemotaxis (measured by L17 migration
response to MLE CM or MLF CM) was changed synergis-
tically by the addition of additional chemokinetic stimulators
into the assay system. This may be due to the different
intracellular signalling pathways of chemotaxis and
chemokinesis. The observations by Kohn et al. (1990) that
the chemotaxis of A2058 human melanoma cells induced by
insulin-like growth factor I (IGF-I), IGF-II or insulin was
enhanced synergistically by an autocrine motility factor and
was not inhibited by pertussis toxin, which inhibits autocrine
motility, seem to support the speculation that different sig-
nalling pathways exist for chemotaxis and chemokinesis.
Lung microvessel endothelial cells and lung fibroblasts
appear to secrete chemotactic factors, and RAW117 and
other tumour cells probably respond in an organ-specific
manner. In the RAW117 cell system the highly lung meta-
static L17 cells also respond to autocrine motility factor, and
it is likely that both of these responses play a role in lung
metastasis. Further analyses using various types of experi-
mental metastatic models will be necessary to establish the
generality of the observations reported here.
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